Vladimir R Muzykantov Selected Research

Lung Diseases (Lung Disease)

1/2018	The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).
10/2012	Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.
9/2008	Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir R Muzykantov Research Topics

Disease

30	Inflammation (Inflammations) 01/2022 - 05/2003
18	Ischemia 08/2017 - 08/2003
17	Thrombosis (Thrombus) 01/2020 - 03/2002
9	Hemorrhage 01/2017 - 10/2003
8	Acute Lung Injury 08/2015 - 03/2002
7	Neoplasms (Cancer) 01/2021 - 08/2011
6	Lung Injury 02/2022 - 03/2002
6	Pneumonia (Pneumonitis) 01/2022 - 01/2014
5	Reperfusion Injury 01/2017 - 04/2003
4	Stroke (Strokes) 03/2012 - 10/2003
4	Hyperoxia 02/2012 - 01/2006
3	Sepsis (Septicemia) 02/2022 - 01/2006
3	Lung Diseases (Lung Disease) 01/2018 - 09/2008
3	Edema (Dropsy) 07/2011 - 08/2009
2	Ischemic Stroke 01/2021 - 04/2010
2	Brain Edema (Cerebral Edema) 01/2020 - 06/2007
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017 - 09/2009
2	Pulmonary Edema 04/2014 - 03/2014
2	Hypotension (Low Blood Pressure) 03/2012 - 11/2011
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2010 - 10/2003
2	Vascular System Injuries 03/2010 - 02/2002
2	Hypertension (High Blood Pressure) 11/2009 - 11/2007
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2006 - 08/2003
1	COVID-19 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Fever (Fevers) 01/2021
1	Pain (Aches) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Adenocarcinoma of Lung 01/2019
1	Radiculopathy (Radiculopathy, Cervical) 09/2017
1	Neuralgia (Stump Neuralgia) 09/2017
1	Endotoxemia 01/2017
1	Hemangioma (Angioma) 04/2014

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 01/2019 - 05/2003
10	EnzymesIBA 09/2017 - 03/2002
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2003
9	CatalaseIBA 01/2017 - 04/2003
8	AntioxidantsIBA 09/2017 - 04/2003
7	ThrombomodulinIBA 01/2020 - 03/2002
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2007
6	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 05/2003
6	FibrinIBA 05/2012 - 08/2003
6	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2012 - 09/2008
5	EndotoxinsIBA 01/2018 - 08/2009
5	Superoxides (Superoxide)IBA 01/2016 - 11/2007
5	Platelet Endothelial Cell Adhesion Molecule-1IBA 07/2015 - 03/2002
4	CytokinesIBA 01/2022 - 03/2014
4	AntibodiesIBA 01/2020 - 09/2008
4	Superoxide DismutaseIBA 01/2018 - 07/2011
4	Immunoglobulin G (IgG)IBA 04/2014 - 09/2009
3	AntigensIBA 01/2021 - 03/2002
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2016 - 06/2007
3	ProdrugsIBA 02/2016 - 11/2009
3	Plasminogen Activators (Plasminogen Activator)IBA 02/2016 - 09/2006
3	Oxidants (Oxidizing Agents)IBA 10/2012 - 03/2002
3	Glucose OxidaseIBA 11/2009 - 03/2002
2	Drug CarriersIBA 01/2022 - 09/2008
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020 - 02/2014
2	Thromboplastin (Tissue Factor)IBA 08/2017 - 02/2008
2	Single-Chain AntibodiesIBA 01/2017 - 06/2007
2	Protein CIBA 01/2017 - 01/2013
2	Hemostatics (Antihemorrhagics)IBA 02/2016 - 08/2013
2	ontuxizumabIBA 04/2014 - 03/2014
2	Cell Adhesion MoleculesIBA 01/2014 - 01/2006
2	LigandsIBA 08/2013 - 06/2011
2	Thrombin FDA Link 05/2012 - 01/2012
2	Oxygen (Dioxygen)IBA 11/2009 - 10/2003
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 08/2008 - 01/2006
2	AcidsIBA 08/2008 - 01/2006
1	Fibrinogen (Factor I)FDA Link 02/2022
1	Lipid NanoparticlesIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	NucleosidesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2018
1	Interleukin-27 (Interleukin 27)IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Interferon-betaIBA 01/2018
1	Immunoglobulin FragmentsIBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2016
1	Firefly LuciferasesIBA 04/2014
1	Liposomes (Liposome)IBA 03/2014
1	EUK-134IBA 03/2014

Therapy/Procedure

12	Therapeutics 01/2022 - 08/2003
3	Intravenous Injections 04/2014 - 02/2002
2	Drug Therapy (Chemotherapy) 07/2015 - 08/2013
2	Lung Transplantation 08/2011 - 01/2006
1	Immunotherapy 01/2021
1	Thrombectomy 01/2021
1	Catheters 01/2021
1	Precision Medicine 04/2014
1	Quantum Dots (Quantum Dot) 02/2014